Westerberg et al. reported that, by analyzing the data of adult out patients, FGF23 level was significantly elevated in those with CKD stage 4 or 5, but not in those with CKD stage 3, compared with subjects with CKD stage 1–2 [32]. Here, FGF23 is linked to chronic kidney disease.